Showing results (181-190 of 12,169) with videos related to
Sort By:
Pageof 1,217
Journal of Cardiovascular Pharmacology|November 14, 2018
Combined Antihypertensive Therapies That Increase Expression of Cardioprotective Biomarkers Associated With the Renin-Angiotensin and Kallikrein-Kinin SystemsDiego Lezama-Martinez, Jazmin Flores-Monroy, Salvador Fonseca-Coronado, et al.Journal of Cardiovascular Pharmacology|November 14, 2018
An Orally Available NLRP3 Inflammasome Inhibitor Prevents Western Diet-Induced Cardiac Dysfunction in MiceSalvatore Carbone, Adolfo G Mauro, Andrea Prestamburgo, et al.Journal of Cardiovascular Pharmacology|September 10, 2019
BaiJiu Increases Nitric Oxide Bioactivity of Chinese Herbs Used to Treat Coronary Artery Disease Through the NO3--NO2--NO PathwayYaoping Tang, Ying Liu, Bangqiao Yin, et al.Journal of Cardiovascular Pharmacology|July 30, 2019
Association of MMP-1 (rs1799750)-1607 2G/2G and MMP-3 (rs3025058)-1612 6A/6A Genotypes With Coronary Artery Disease Risk Among Iranian TurksAyda Ghaffarzadeh, Morteza Bagheri, Kamal Khadem-Vatani, et al.Journal of Cardiovascular Pharmacology|July 30, 2019
Infusion of Melatonin Into the Paraventricular Nucleus Ameliorates Myocardial Ischemia-Reperfusion Injury by Regulating Oxidative Stress and Inflammatory CytokinesJin-Bao Yang, Yu-Ming Kang, Chao Zhang, et al.Journal of Cardiovascular Pharmacology|July 30, 2019
Alirocumab in Acute Myocardial Infarction: Results From the Virginia Commonwealth University Alirocumab Response Trial (VCU-AlirocRT)Cory R Trankle, George Wohlford, Leo F Buckley, et al.Journal of Cardiovascular Pharmacology|July 30, 2019
Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical OutcomesLeo F Buckley, Peter LibbyJournal of Cardiovascular Pharmacology|July 30, 2019
NLRP3 Inflammasome in Cardioprotective SignalingCoert J ZuurbierJournal of Cardiovascular Pharmacology|July 30, 2019
Xanthoangelol Prevents Ox-LDL-Induced Endothelial Cell Injury by Activating Nrf2/ARE SignalingRui Yan, Jifeng Yan, Xiaozhen Chen, et al.Journal of Cardiovascular Pharmacology|July 30, 2019
Kaempferol Prevents Against Ang II-induced Cardiac Remodeling Through Attenuating Ang II-induced Inflammation and Oxidative StressYao Du, Jibo Han, Haixia Zhang, et al.Pageof 1,217